![Simon Benito](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simon Benito
Président chez
INOVIO PHARMACEUTICALS, INC.
Fortune : 15 483 $ au 31/08/2026
Profil
Simon X.
Benito is currently the Chairman at Inovio Pharmaceuticals, Inc. He previously held positions as a Director at Genetronics Biomedical Corp., an Independent Director at DURECT Corp., and as an Executive Director & Vice President at Merck Human Health US.
He also served as the Senior Vice President-Vaccine Division at Merck & Co., Inc. and as the Executive Vice President-Medco Managed Care at Merck-Medco Managed Care LLC.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/05/2026 | 12 191 ( 0,01% ) | 15 483 $ | 31/08/2026 |
Postes actifs de Simon Benito
| Sociétés | Poste | Début |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Président | 03/01/2019 |
Anciens postes connus de Simon Benito
| Sociétés | Poste | Fin |
|---|---|---|
| DURECT | Directeur/Membre du Conseil | 15/06/2022 |
Genetronics Biomedical Corp.
 Genetronics Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Specializes in targeted intracellular delivery of therapeutic molecules | Directeur/Membre du Conseil | 05/04/2005 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/1999 |
Merck-Medco Managed Care LLC
 Merck-Medco Managed Care LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | 01/01/1996 |
Merck Human Health US | Directeur/Membre du Conseil | 01/01/1993 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Genetronics Biomedical Corp.
Genetronics Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Specializes in targeted intracellular delivery of therapeutic molecules | Commercial Services |
DURECT Corp.
 DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases | Health Technology |
Merck-Medco Managed Care LLC
Merck-Medco Managed Care LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Inovio Pharmaceuticals, Inc.
 Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
Merck Human Health US |
